Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ajjai Alva"'
Autor:
Monika Joshi, Rohan Garje, D.J. Peace, Ajjai Alva, Yi Sun, Eric A. Singer, A. Lee, Yousef Zakharia
Publikováno v:
Annals of Oncology. 31:S594-S595
Autor:
Lajos Géczi, Evan Y. Yu, Alejo Rodriguez-Vida, Seyda Gunduz, Nobuaki Matsubara, Yves Fradet, Ajjai Alva, Thomas Powles, R. Morales Barrera, Ronac Mamtani, Aude Flechon, Kijoeng Nam, Mustafa Ozguroglu, Christof Vulsteke, Yohann Loriot, Kentaro Imai, S.Y-S. Cheng, Tibor Csőszi, Stéphane Oudard, Blanca Homet Moreno
Publikováno v:
Annals of Oncology. 31:S1155
Autor:
Ajjai Alva, S. Yentz
Publikováno v:
Annals of Oncology. 28:v328-v329
Autor:
Jeremy Cetnar, Peter H. O'Donnell, Amir Mortazavi, T. Chen, Neal D. Shore, Emmett V. Schmidt, J. Burke, B. Bitman, Noah M. Hahn, C. Kresja, Mark D. Fleming, Leonard Joseph Appleman, Ajjai Alva, R. Izumi, Matthew I. Milowsky, A. Hamdy, Tian Zhang, Michael R. Harrison, Daniel J. George
Publikováno v:
Annals of Oncology. 28:v303-v304
Autor:
Richard C. Chao, Byoung Chul Cho, James G. Christensen, D. Potvin, Richard D. Carvajal, Ajjai Alva, K. Eaton, M. Ingham, Ding Wang, Swati Goel, Lyudmilla Bazhenova, Rebecca S. Heist, S. Neuteboom, Theresa L. Werner, Isan Chen
Publikováno v:
Annals of Oncology. 29:viii133
Autor:
Jürgen E. Gschwend, Woo Kyun Bae, Lajos Géczi, D. Feng, Rustem Gafanov, Christian Heinrich Poehlein, Urbano Anido, Maurice Markus, Yohann Loriot, Mahmoud Abdelsalam, Joaquim Bellmunt, Mark D. Fleming, Ajjai Alva, W. Su, Thomas Powles, Yoshiaki Yamamoto, János Révész, Christof Vulsteke
Publikováno v:
Annals of Oncology. 28:v326
Autor:
Ajjai Alva, Jonathan E. Rosenberg, M. Liontos, U. De Giorgi, Evan Y. Yu, Neeraj Agarwal, Lauren C. Harshman, Y.-N. Wong, Simon J. Crabb, Cora N. Sternberg, Guenter Niegisch, Joaquim Bellmunt, Sandhya Srinivas, Sylvain Ladoire, Aristotle Bamias, Risc Investigators, Sumanta K. Pal, Thomas Powles, Kimon Tzannis
Publikováno v:
Annals of Oncology. 27:vi278
Autor:
Stephanie Daignault-Newton, Tamara Huebner, C. Ionescu, Ajjai Alva, M. Clark, Rohit Mehra, M. Schwartz
Publikováno v:
Annals of Oncology. 25:iv78
Aim: Cisplatin based neoadjuvant chemotherapy (NAC) improves survival in some patients with resectable muscle-invasive bladder cancer but carries significant toxicity. Development of predictive biomarkers to direct NAC is an urgent clinical need, Cir